Jazz Pharma Hits the Mark with Another Narcolepsy Treatment

[cafead]

via An investigational medicine in late-stage development by Jazz Pharmaceuticals hit the mark in treating cataplexy and excessive daytime sleepiness (EDS) in adults with narcolepsy. The drug also has the benefit of a lower sodium content, which is crucial due to narcolepsy’s association with an increased risk of comorbid conditions, including hypertension and cardiovascular disease.

article source